- Home
- ASO vs OPCH Comparison
ASO vs OPCH Comparison
Compare ASO & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$46.76
HOLD
Current Price
$21.60
Company Overview
Basic Information| Metric | ASO | OPCH |
|---|---|---|
| Founded | 1938 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ASO | OPCH |
|---|---|---|
| Price | $46.76 | $21.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $58.08 | $36.57 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 06-09-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | ★ 0.80 | 0.29 |
| Revenue | ★ $6,053,414,000.00 | $4,998,202,000.00 |
| Revenue This Year | $5.13 | $7.21 |
| Revenue Next Year | $5.36 | $8.55 |
| P/E Ratio | ★ $58.83 | $72.69 |
| Revenue Growth | 2.02 | ★ 16.17 |
| 52 Week Low | $41.29 | $18.01 |
| 52 Week High | $62.45 | $36.80 |
Technical Indicators
Market Signals| Indicator | ASO | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 50.11 |
| Support Level | $43.72 | $20.82 |
| Resistance Level | $59.97 | $22.43 |
| Average True Range (ATR) | 1.62 | 0.60 |
| MACD | 0.24 | -0.03 |
| Stochastic Oscillator | 45.90 | 49.85 |
Price Performance
Historical Comparison ASO
OPCH
About ASO Academy Sports and Outdoors Inc.
Academy Sports and Outdoors Inc is engaged in the full-line sporting goods and outdoor recreation retailer in the United States. The company's product categories are outdoors, apparel, sports & recreation, and footwear.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.